Pangen Biotech signs US$0.5m CMO with SCD Pharm

11:31
[From the Scene] Immersive heritage exhibition opens in Gangneung, Las Vegas
10:51
Opposition leader faces sentencing hearing over allegedly suborning perjury this week
10:06
golden horse caption
09:41
Japan voices regret over S. Korea's non-attendance of Sado memorial
16:13
S. Korea not to attend Sado mine memorial: foreign ministry
16:01
Gyeongju blends old with new
16:01
[What to Play] Cozy songs to warm you up
16:01
[Weekender] Korea's traditional sauce culture gains global recognition
16:01
Toxins at 622 times legal limit found in kids' clothes from Chinese platforms
16:01
At Gwangcheonok, try North Korean-style sundae gukbap

Pangen Biotech signs US$0.5m CMO with SCD Pharm

June 29, 2016 - 15:31 By 황유미

[DISCLOSURE] Pangen Biotech (222110) has signed a 600 million won (US$513,479) contract manufacturing agreement with SamChunDang Pharm (000250) to supply protein, it announced on June 29. This amounts to 16.1 percent of its recent revenue.

황유미